Contact frequency determines outcome of basal insulin initiation trials in type 2 diabetes

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

David M. Nathan, John B. Buse, Mayer B. Davidson et al. · Diabetes Care · 2008 · 3.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Health Policy +14

The Treat-to-Target Trial

Matthew C. Riddle, Julio Rosenstock, John Gerich · Diabetes Care · 2003 · 1.5K citations · Full text

A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes

Kjeld Hermansen, Melanie J. Davies, Tadeusz Dereziński et al. · Diabetes Care · 2006 · 629 citations · Full text

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

Hannele Yki‐Järvinen, A. Dressler, M. Ziemen · Diabetes Care · 2000 · 580 citations · Full text

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

Julio Rosenstock, Melanie J. Davies, Philip Home et al. · Diabetologia · 2008 · 446 citations · Full text